Option Care Health, Inc. $OPCH holdings increased by Isthmus Partners LLC. Posted by ABMN Staff on Oct 23rd, 2026 Isthmus Partners LLC boosted its stake in Option Care Health, Inc. (NASDAQ:OPCH - Free Report) by 37.9% during the 3rd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 169,172 shares of the company's stock after acquiring an additional 46,518 shares during the period. Isthmus Partners LLC owned 0.11% of Option Care Health worth $3,805,000 at the end of the most recent reporting period. A number of other hedge funds have also added to or reduced their stakes in the stock. Reyes Financial Architecture Inc. purchased a new position in shares of Option Care Health during the third quarter valued at about $28,000. Pinnacle Associates Ltd. lifted its holdings in Option Care Health by 1.8% in the third quarter. Pinnacle Associates Ltd. now owns 20,355 shares of the company's stock worth $458,000 after buying an additional 354 shares during the period. Nisa Investment Advisors LLC boosted its position in Option Care Health by 268.9% during the 3rd quarter. Nisa Investment Advisors LLC now owns 2,955 shares of the company's stock valued at $66,000 after acquiring an additional 2,154 shares in the last quarter. Fort Washington Investment Advisors Inc. OH grew its holdings in shares of Option Care Health by 5.1% during the 3rd quarter. Fort Washington Investment Advisors Inc. OH now owns 1,421,567 shares of the company's stock worth $31,971,000 after acquiring an additional 68,572 shares during the period. Finally, Central Pacific Bank Trust Division grew its holdings in shares of Option Care Health by 3.9% during the 3rd quarter. Central Pacific Bank Trust Division now owns 14,369 shares of the company's stock worth $323,000 after acquiring an additional 540 shares during the period. 98.05% of the stock is owned by hedge funds and other institutional investors. Option Care Health stock performance. Shares of Option Care Health stock opened at $31.29 on Friday. The business has a 50-day moving average of $25.57 and a 200 day moving average of $23.84. Option Care Health, Inc. has a 12 month low of $18.01 and a 12 month high of $36.80. The stock has a market capitalization of $4.69 billion, a price-to-earnings ratio of 19.80, a price-to-earnings-growth ratio of 1.90 and a beta of 0.58. The company has a debt-to-equity ratio of 0.91, a current ratio of 1.47 and a quick ratio of 0.98. Discover more Read Daily News Option Care Health (NASDAQ:OPCH - Get Free Report) last released its earnings results on Wednesday, July 29th. The company reported $0.45 earnings per share for the quarter, beating the consensus estimate of $0.43 by $0.02. The company had revenue of $1.44 billion during the quarter, compared to the consensus estimate of $1.42 billion. Option Care Health had a return on equity of 18.74% and a net margin of 3.68%. Option Care Health's revenue was up 1.9% compared to the same quarter last year. During the same period in the previous year, the company posted $0.41 EPS. Option Care Health has set its FY 2026 guidance at 1.850-1.920 EPS. As a group, sell-side analysts forecast that Option Care Health, Inc. will post 1.70 earnings per share for the current year. Wall street analysts forecast growth. Several brokerages have recently issued reports on OPCH. Jefferies Financial Group lowered Option Care Health from a "buy" rating to a "hold" rating and increased their target price for the stock from $28.00 to $32.05 in a research report on Tuesday, October 6th. Barrington Research lowered shares of Option Care Health from an "outperform" rating to a "hold" rating in a research report on Wednesday, October 7th. UBS Group lowered Option Care Health from a "buy" rating to a "neutral" rating and dropped their target price for the company from $39.00 to $32.05 in a research report on Friday, October 9th. Morgan Stanley set a $32.05 price target on shares of Option Care Health in a research report on Monday, October 12th. Finally, JPMorgan Chase & Co. reaffirmed a "neutral" rating and issued a $33.00 price target on shares of Option Care Health in a research note on Wednesday, October 7th. Two investment analysts have rated the stock with a Buy rating and fourteen have assigned a Hold rating to the company's stock. Based on data from MarketBeat.com, Option Care Health presently has an average rating of "Hold" and an average price target of $29.48. About Option Care Health. Option Care Health, Inc is an independent provider of home and alternate-site infusion services in the United States. The company coordinates and delivers infusion therapy outside traditional hospital settings, including patients' homes, ambulatory infusion suites and other outpatient locations. Its services include administration of anti-infective therapies, immune globulin, nutrition support, inotropic therapies and medications used in the treatment of chronic and complex conditions. Want to see what other hedge funds are holding OPCH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Option Care Health, Inc. (NASDAQ:OPCH - Free Report). Receive News & Ratings for Option Care Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Option Care Health and related companies with MarketBeat.com's FREE daily email newsletter.

McKesson will invest $1.4 billion for a 49% minority stake in Option Care Health, under an agreement announced on October 6, 2026. The deal values Option Care at an enterprise value of $5.8 billion. Clayton, Dubilier & Rice will hold about 51%. Option Care will stay separately managed, while McKesson keeps a framework to acquire the remaining interest later, subject to conditions and regulatory approvals. In its first fiscal 2027 quarter, McKesson reported revenue of $105.38 billion, up 7.7% year on year, and adjusted earnings per share of $9.93. It will report second-quarter results on November 4, 2026.

Option Care Health shares jumped 33.2% in pre-market trading after the Financial Times reported McKesson and Clayton Dubilier & Rice are nearing a transaction valued at over $5 billion to acquire the alternate site health provider. According to the report, the deal would involve the two firms partnering to buy the infusion services provider, which they view as undervalued. Large-scale buyout discussions typically drive market optimism as investors anticipate acquisition premiums. The move is significant for Option Care Health, whose shares have experienced 13 movements greater than 5% over the past year. At $31.03 per share, the stock is trading 15.2% below its 52-week high but remains down 3.8% year-to-date.